Two of these 35 mRNAs, PDLIM7 and FOXK1, showing a significant and positive association with both, IGF2BP1 and SRF expression in cancer, as indicated for HCC and EOC (Supplementary Figure S6C), were chosen for validating regulation by IGF2BP1 and SRF. The gene discussed is SRF; the disease is hepatocellular carcinoma.